Multiples Alternate Asset Management has partially exited India-based multiplex chain operator PVR for INR.179b (approximately USD24.5m) through open market transactions. Read more… Read More
Tata Consumer Products has agreed to acquire 100% of Kottaram Agro Foods, an India-based packaged foods startup backed by Aavishkaar Capital, for USD21.3m. Read more… Read More
Sequoia Capital India has partially exited its stake in India-based paint manufacturer Indigo Paints via the company’s INR11.76b (approximately USD161m) IPO. Sequoia Capital sold 4.165m shares for INR6.19b (~USD84.6m). Read more… Read More
DEG has committed USD22m to Openspace Ventures Fund III, a Southeast Asia-focused fund managed by Openspace Ventures. The fund reached a USD90m+ first close in June 2020 and has a target of USD200m. Read more… Read More
China-based short video and live streaming app Kuaishou has raised HKD42b (approximately USD5.4b) in its IPO on the HKEX. Underwriters fully exercised the overallotment option, bringing the total capital raised to HKD48.2b (approximately USD6.2b). Ten cornerstone investors including GIC, Temasek, the Abu Dhabi Investment Authority, CPP Investments,… Read More
Quona Capital and B Capital Group led a USD20m Series A for Ula, an Indonesia-based e-commerce marketplace for small retailers, with follow-on from Sequoia Capital India and Lightspeed India Partners. Read more… Read More
UTI Capital has reached a USD54m first close for its UTI Structured Debt Opportunities Fund II. The vehicle has an initial target of USD137m and will focus on investments in the health care, education, food and agriculture, and renewable energy sectors in India. Read more… Read More
Lake Bleu Capital has reached a USD560m final close for its latest health care fund targeting late-stage investments across biotech, medical technology, and health care services in China. Read more… Read More
General Atlantic has invested USD55m in Indonesia-based biotech firm Kalbe Genexine Biologics, a joint venture between Indonesian pharmaceuticals company PT Kalbe Farma and South Korean biotech developer Genexine. Read more… Read More
Stride Ventures has reached a INR3.5b (approximately USD48m) final close for its debut India venture debt fund. The vehicle will invest in growth-stage companies, with a focus on B2B and D2C companies, in India. Read more… Read More
(default archive template)